Health Care
More on Health Care
Washington, D.C. (Sept. 23, 2015)—Today, Rep. Elijah E.
Ranking Member Elijah Cummings: Former Hedge Fund Manager Should Testify about "Overnight" Price Increase for Life-Saving Drug
Washington, D.C. (Sept. 22, 2015)—Today, Rep. Elijah E.
Cummings and Sanders Investigate "Overnight" Price Increase of Life-Saving Drug
Washington, D.C. (Sept. 21, 2015)—As a part of their ongoing investigation into recent drug price increases, Rep. Elijah E.
Remarks of Rep. Elijah E. Cummings
Ranking Member, House Committee on Oversight and Government Reform
Press Conference: Prescription Drug Affordability Act September 10, 2015
I am very pleased to be here today, and I thank Senator Sanders for his strong leadership on this issue.
Senator Sanders did a terrific job laying out the specifics of what is in the bill, so let me just add a couple of points.
Sanders, Cummings Introduce Comprehensive Legislation to Lower Soaring Drug Prices
WASHINGTON, Sept. 10 – Sen. Bernie Sanders (I-Vt.) and House Oversight and Government Reform Committee Ranking Member Elijah Cummings (D-Md.) today introduced legislation to address skyrocketing increases in prescription drug prices.
Top House Dems Call on Chairmen to Suspend "One-Sided" Investigations of Planned Parenthood— Or Fully Investigate Numerous Allegations of Illegal Activity by David Daleiden and His Group
Washington, D.C. (Sept. 3, 2015)—Today, Rep. Elijah E. Cummings, Ranking Member of the Committee on Oversight and Government Reform, and Rep. John J.
Efforts by Casey, Wyden, and Cummings Lead to GAO Study of CMS Nursing Home Rating System
News Reports Have Raised Concerns About Integrity, Transparency of Five-Star Quality Rating System
Washington, D.C. (Aug. 31, 2015)—Today, Rep. Elijah E.
Documents Sought From Group That May Have Violated Law in Targeting Planned Parenthood
Washington, D.C. (Aug. 20, 2015)—Today, Rep. Elijah E.
Cummings Issues Detailed Statement on New Report on Skyrocketing Drug Prices
Washington, D.C. (Aug. 20, 2015)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to a new report from the Kaiser Family Foundation reporting that Republican voters are more concerned about escalating prescription drug prices than the Affordable Care Act: